AU Stock MarketDetailed Quotes

PYCDA PYC Therapeutics Ltd

Watchlist
  • 1.850
  • +0.010+0.54%
20min DelayMarket Closed Nov 25 16:00 AET
863.23MMarket Cap-19270P/E (Static)

PYC Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
Total revenue
Cost of revenue
Gross profit
Operating expense
54.28%60.42M
29.65%39.16M
38.36%30.21M
124.05%21.83M
9.74M
Selling and administrative expenses
-5.43%2.4M
-41.95%2.54M
-29.09%4.38M
8.92%6.18M
--5.67M
-General and administrative expense
-5.43%2.4M
-41.95%2.54M
-29.09%4.38M
8.92%6.18M
--5.67M
Research and development costs
60.50%56.41M
46.25%35.15M
71.60%24.03M
--14M
----
Depreciation amortization depletion
9.01%600.88K
-34.34%551.22K
34.89%839.51K
13.75%622.36K
--547.11K
-Depreciation and amortization
9.01%600.88K
-34.34%551.22K
34.89%839.51K
13.75%622.36K
--547.11K
Other operating expenses
9.28%1.01M
-3.57%923.49K
-7.06%957.73K
-70.78%1.03M
--3.53M
Operating profit
-54.28%-60.42M
-29.65%-39.16M
-38.36%-30.21M
-124.05%-21.83M
-9.74M
Net non-operating interest income (expenses)
1,268.68%746.77K
767.82%54.56K
-111.73%-8.17K
-66.34%69.68K
207.03K
Non-operating interest income
872.49%795.98K
235.10%81.85K
-77.49%24.43K
-47.59%108.5K
--207.03K
Non-operating interest expense
80.33%49.21K
-16.28%27.29K
-16.04%32.6K
--38.82K
----
Other net income (expenses)
36.91%21.57M
-1.07%15.75M
408.17%15.92M
4,913.07%3.13M
62.5K
Other non-operating income (expenses)
36.91%21.57M
-1.07%15.75M
408.17%15.92M
4,913.07%3.13M
--62.5K
Income before tax
-63.17%-38.11M
-63.40%-23.36M
23.27%-14.29M
-96.62%-18.63M
-9.48M
Income tax
0
0
0
0
-2.4M
Earnings from equity interest net of tax
Net income
-63.17%-38.11M
-63.40%-23.36M
23.27%-14.29M
-163.15%-18.63M
-7.08M
Net income continuous operations
-63.17%-38.11M
-63.40%-23.36M
23.27%-14.29M
-163.15%-18.63M
---7.08M
Noncontrolling interests
32.15%-385.05K
-31.73%-567.5K
50.05%-430.81K
-235.15%-862.42K
-257.32K
Net income attributable to the company
-65.54%-37.73M
-64.39%-22.79M
21.97%-13.86M
-160.44%-17.77M
-6.82M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-65.54%-37.73M
-64.39%-22.79M
21.97%-13.86M
-160.44%-17.77M
-6.82M
Diluted earnings per share
-36.82%-0.096
-61.37%-0.0702
22.81%-0.0435
-120.72%-0.0563
-0.0255
Basic earnings per share
-36.82%-0.096
-61.37%-0.0702
22.81%-0.0435
-120.72%-0.0563
-0.0255
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020
Total revenue
Cost of revenue
Gross profit
Operating expense 54.28%60.42M29.65%39.16M38.36%30.21M124.05%21.83M9.74M
Selling and administrative expenses -5.43%2.4M-41.95%2.54M-29.09%4.38M8.92%6.18M--5.67M
-General and administrative expense -5.43%2.4M-41.95%2.54M-29.09%4.38M8.92%6.18M--5.67M
Research and development costs 60.50%56.41M46.25%35.15M71.60%24.03M--14M----
Depreciation amortization depletion 9.01%600.88K-34.34%551.22K34.89%839.51K13.75%622.36K--547.11K
-Depreciation and amortization 9.01%600.88K-34.34%551.22K34.89%839.51K13.75%622.36K--547.11K
Other operating expenses 9.28%1.01M-3.57%923.49K-7.06%957.73K-70.78%1.03M--3.53M
Operating profit -54.28%-60.42M-29.65%-39.16M-38.36%-30.21M-124.05%-21.83M-9.74M
Net non-operating interest income (expenses) 1,268.68%746.77K767.82%54.56K-111.73%-8.17K-66.34%69.68K207.03K
Non-operating interest income 872.49%795.98K235.10%81.85K-77.49%24.43K-47.59%108.5K--207.03K
Non-operating interest expense 80.33%49.21K-16.28%27.29K-16.04%32.6K--38.82K----
Other net income (expenses) 36.91%21.57M-1.07%15.75M408.17%15.92M4,913.07%3.13M62.5K
Other non-operating income (expenses) 36.91%21.57M-1.07%15.75M408.17%15.92M4,913.07%3.13M--62.5K
Income before tax -63.17%-38.11M-63.40%-23.36M23.27%-14.29M-96.62%-18.63M-9.48M
Income tax 0000-2.4M
Earnings from equity interest net of tax
Net income -63.17%-38.11M-63.40%-23.36M23.27%-14.29M-163.15%-18.63M-7.08M
Net income continuous operations -63.17%-38.11M-63.40%-23.36M23.27%-14.29M-163.15%-18.63M---7.08M
Noncontrolling interests 32.15%-385.05K-31.73%-567.5K50.05%-430.81K-235.15%-862.42K-257.32K
Net income attributable to the company -65.54%-37.73M-64.39%-22.79M21.97%-13.86M-160.44%-17.77M-6.82M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -65.54%-37.73M-64.39%-22.79M21.97%-13.86M-160.44%-17.77M-6.82M
Diluted earnings per share -36.82%-0.096-61.37%-0.070222.81%-0.0435-120.72%-0.0563-0.0255
Basic earnings per share -36.82%-0.096-61.37%-0.070222.81%-0.0435-120.72%-0.0563-0.0255
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data